Dual functions of SHP-2 tyrosine phosphatase in colorectal cancer

4^th World Congress on Cancer Science & Therapy

October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore Conference Center, USA

Nathalie Rivard

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

Colorectal cancer (CRC) is the third most common cancer in the world. A major risk factor to develop CRC is the presence of chronic inflammation in the colon. But how chronic inflammation contributes to the development of CRC is not so clear. In seeking to answer this question, we have focused on the signalling molecule SHP-2, a tyrosine phosphatase modulating cellular signals induced by both growth factors and pro-inflammatory cytokines. Polymorphisms in the PTPN11 locus encoding SHP-2 have been reported to be markers of colitis susceptibility. Conversely, gain-of-function mutations in PTPN11 have recently been associated with sporadic CRC. To investigate the role of SHP-2 in intestinal homeostasis, we have generated mice with an intestinal epithelial cell (IEC)-specific deletion of its expression. We demonstrated that IEC disruption of SHP-2 causes severe chronic inflammation in the colon. This inflammatory phenotype is associated with a dramatic increase in proliferation and activation of Wnt/β-catenin, NFkB and STAT3 signallings in colonic epithelium. With age, these mice develop malignant lesions in the colon suggesting that SHP-2 can act as a tumor suppressor in this tissue. Furthermore, SHP-2 epithelial deficiency severely increased colon tumor load in apcmin/+mice. Aside from these observations, we found increased expression and activating mutations of SHP-2 in sporadic human colorectal tumors and SHP-2 silencing markedly attenuated KRAS-induced transformation of IECs in culture. Hence, this suggests that SHP-2 can act as an oncogene in the colonic epithelium. Opposing roles for SHP-2in promoting and suppressing tumorigenesis in the large intestine are therefore proposed.

Biography :

Nathalie Rivard received her PhD from Université de Sherbrooke in 1994 and completed a 3.5-year Postdoctorate at the Centre de Biochimie-CNRS, Université de Nice, in France with Dr. J.Pouysségur in 1997. Then, she accepted a Faculty position in the Department of Anatomy and Cell Biology at the Université de Sherbrooke. Her research focuses on the analysis of signalling pathways that control proliferation, differentiation, tumorigenesis and inflammatory response of intestinal epithelial cells. She has published more than 80 papers in reputed journals. She is the recipient of 2013 Canadian Association of Gastroenterology Research Excellence Award andholds a Canada Research Chair.